BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 7843825)

  • 1. The injectable cephalosporins in the treatment of serious infections.
    Jones RN
    Infection; 1994; 22 Suppl 3():S182-3. PubMed ID: 7843828
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of severe infections caused by penicillin-resistant pneumococci. Role of third generation cephalosporins.
    Rubinstein E; Rubinovitch B
    Infection; 1994; 22 Suppl 3():S161-6. PubMed ID: 7843825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pneumococcal antibiotic resistance].
    Moreillon P; Wenger A; Caldelari I
    Rev Med Suisse Romande; 2000 Aug; 120(8):651-9. PubMed ID: 11028185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antibiotic resistance in pneumococci].
    Moreillon P; Wenger A
    Schweiz Med Wochenschr; 1996 Feb; 126(7):255-63. PubMed ID: 8720323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the effect of cefepime with four cephalosporins against pneumococci with various susceptibilities to penicillin, in vitro and in the mouse peritonitis model.
    Knudsen JD; Fuursted K; Frimodt-Møller N; Espersen F
    J Antimicrob Chemother; 1997 Nov; 40(5):679-86. PubMed ID: 9421316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Resistance to Streptococcus pneumoniae to penicillin and its association with clinical and epidemiological factors].
    Contreras L; Fica A; Figueroa O; Enríquez N; Urrutia P; Herrera P
    Rev Med Chil; 2002 Jan; 130(1):26-34. PubMed ID: 11961958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of penicillin and three third-generation cephalosporins against US isolates of Streptococcus pneumoniae: a 1995 surveillance study.
    Thornsberry C; Burton PH; Vanderhoof BH
    Diagn Microbiol Infect Dis; 1996 Jun; 25(2):89-95. PubMed ID: 8882895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Underutilization of pneumococcal vaccine in nursing home in Washington State: report of a serotype-specific outbreak and a survey.
    Quick RE; Hoge CW; Hamilton DJ; Whitney CJ; Borges M; Kobayashi JM
    Am J Med; 1993 Feb; 94(2):149-52. PubMed ID: 8430710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A brief history of the pneumococcus in biomedical research: a panoply of scientific discovery.
    Watson DA; Musher DM; Jacobson JW; Verhoef J
    Clin Infect Dis; 1993 Nov; 17(5):913-24. PubMed ID: 8286641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The assessment of pneumococcal vaccine.
    Austrian R
    N Engl J Med; 1980 Sep; 303(10):578-80. PubMed ID: 7402223
    [No Abstract]   [Full Text] [Related]  

  • 11. Characteristics of rifampin-resistant variants obtained from clinical isolates of Staphylococcus aureus.
    Moorman DR; Mandell GL
    Antimicrob Agents Chemother; 1981 Dec; 20(6):709-13. PubMed ID: 7325636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An epidemiologic approach to pneumococcal disease.
    Riley ID; Douglas RM
    Rev Infect Dis; 1981; 3(2):233-45. PubMed ID: 7256085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased resistance to penicillin of pneumococci isolated from man.
    Hansman D; Glasgow H; Sturt J; Devitt L; Douglas R
    N Engl J Med; 1971 Jan; 284(4):175-7. PubMed ID: 4395334
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.